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Background: A diverse set of neurodegenerative disorders are caused by abnormal extensions of polyglutamine
(poly-Q) stretches in various, functionally unrelated proteins. A common feature of these diseases is altered
proteostasis. Autophagy induction is part of the endogenous response to poly-Q protein expression. However, if
autophagy is not resolved properly, clearance of toxic proteins or aggregates cannot occur effectively. Likewise,
excessive autophagy induction can cause autophagic stress and neurodegeneration. The Lipocalins ApoD, Glial
Lazarillo (GLaz) and Neural Lazarillo (NLaz) are neuroprotectors upon oxidative stress or aging. In this work we test
whether these Lipocalins also protect against poly-Q-triggered deterioration of protein quality control systems.
Results: Using a Drosophila retinal degeneration model of Type-1 Spinocerebellar Ataxia (SCA1) combined with
genetic manipulation of NLaz and GLaz expression, we demonstrate that both Lipocalins protect against SCA1
neurodegeneration. They are part of the endogenous transcriptional response to SCA1, and their effect is non-additive,
suggesting participation in a similar mechanism. GLaz beneficial effects persist throughout aging, and appears when
expressed by degenerating neurons or by retinal support and glial cells. GLaz gain-of-function reduces cell death and
the extent of ubiquitinated proteins accumulation, and decreases the expression of Atg8a/LC3, p62 mRNA and
protein levels, and GstS1 induction. Over-expression of GLaz is able to reduce p62 and ubiquitinated proteins
levels when rapamycin-dependent and SCA1-dependent inductions of autophagy are combined. In the absence
of neurodegeneration, GLaz loss-of-function increases Atg8a/LC3 mRNA and p62 protein levels without altering
p62 mRNA levels. Knocking-down autophagy, by interfering with Atg8a or p62 expression or by expressing
dominant-negative Atg1/ULK1 or Atg4a transgenes, rescues SCA1-dependent neurodegeneration in a similar
extent to the protective effect of GLaz. Further GLaz-dependent improvement is concealed.
Conclusions: This work shows for the first time that a Lipocalin rescues neurons from pathogenic SCA1
degeneration by optimizing clearance of aggregation-prone proteins. GLaz modulates key autophagy genes and
lipid-peroxide clearance responsive genes. Down-regulation of selective autophagy causes similar and non-additive
rescuing effects. These data suggest that SCA1 neurodegeneration concurs with autophagic stress, and places
Lazarillo-related Lipocalins as valuable players in the endogenous protection against the two major contributors to
aging and neurodegeneration: ROS-dependent damage and proteostasis deterioration.
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A diverse set of neurodegenerative disorders are caused by
abnormal extensions of polyglutamine (poly-Q) stretches
in various, functionally unrelated proteins. No effective
treatment to prevent or slow down the progression of
poly-Q-based neurodegeneration is currently available.
Since anomalous glutamine extensions lead to protein mis-
folding and aggregation, independently of the particular
protein affected, all of these diseases display altered cellular
proteostasis [1] as a common feature. The mechanisms en-
gaged in protein quality control, mainly the ubiquitin-
proteasome and autophagy systems, are obvious candidate
processes on which to focus therapeutic manipulations,
aiming at the clearance of mutant proteins. Because poly-
Q proteins tend to oligomerize, autophagy is thought to
play a prominent role in their management. However, au-
tophagic responses to pathological damage are not yet well
understood. Very diverse modes of experimental or
pharmacological induction of autophagy have proven to be
protective in poly-Q disease models (reviewed in [2]). Also,
induction of autophagy has been proposed to be part of
the natural response of cells upon glutamine-extended pro-
tein expression [3]. However, increased levels of autophagy
do not always have beneficial effects on poly-Q-based neu-
rodegeneration. Nisoli et al. [4] showed that induction of
autophagy does not rescue the neurodegeneration caused
by poly-Q-extended atrophin-1 in a fly model of DRPLA
(dentatorubral-pallidoluysian atrophy). If autophagy is in-
duced but not resolved properly, clearance of damaged and
unfolded proteins cannot take place effectively. Also, exces-
sive or imbalanced induction of autophagy might be dele-
terious if autophagosome turnover is unable to keep pace
with its formation [5]. This situation will produce autopha-
gic stress, which can actively contribute to neuronal atro-
phy, neurite degeneration and cell death [6,7].
We have studied the functions of an evolutionarily-
related group of proteins belonging to the Lipocalin fam-
ily, named Lazarillo in invertebrates (Laz, GLaz and
NLaz) and Apolipoprotein D (ApoD) in vertebrates. They
are secreted proteins with a single globular ß-barrel do-
main that forms a “cup-like” structure with ability to bind
small molecules, mostly hydrophobic in nature [8].
Hydrophobic ligands as varied as retinoic acid, arachi-
donic acid, progesterone, sphingomyelin, the pheromone
7(d)tricosene, or the endocannabinoid anandamide,
have been shown to bind to some of these Lazarillo-
related Lipocalins [9-11].
Lazarillo-related Lipocalins show neuroprotective ef-
fects in mice and lifespan extending abilities in flies,
both under normal conditions and upon exposure to
oxidative stress or injury [12-21]. These neuroprotective
functions are mediated either by counteracting lipid per-
oxidation or by controlling myelin phagocytosis in in-
jured nerves [20,22]. Moreover, ApoD stands among asmall set of genes whose over-expression upon nervous
system aging is conserved in mammals [23,24], and its
over-expression is extensively correlated with a wide
spectrum of nervous system damage, like stroke or
meningoencephalitis, psychiatric disorders like schizo-
phrenia or bipolar disorder, and neurodegenerative dis-
eases like Alzheimer, Parkinson, Huntington, Niemann
Pick or multiple sclerosis (reviewed in [25-27]).
Physiological aging and age-related pathologies share
many causal factors (reviewed in [28]), and it is not sur-
prising that protective agents are also shared, even
though the particular form or the rate of damage accu-
mulation might vary. Two of the major factors contrib-
uting to aging and neurodegeneration are (1) reactive
oxygen species (ROS)-mediated damage and (2) deterior-
ation of protein and organelle quality control systems.
We have previously tested the protective effect of a
Lazarillo-related Lipocalin, GLaz, on the degeneration
caused by a primarily mitochondrial dysfunction disease,
Friedreich ataxia, a neurodegenerative disorder with a
redox imbalance as a major contributor to its patho-
physiology. GLaz is able to counteract some of the ef-
fects of frataxin deficiency, reducing the level of lipid
peroxidation and free fatty acids, and leading to im-
proved survival of frataxin-deficient flies [29]. Yet, given
the variety of neurodegenerative conditions that concur
with ApoD over-expression, these Lipocalins are prob-
ably important elements of the shared set of protective
agents. Thus, it is pertinent to ask whether Lipocalins
can protect from neurodegenerative disorders with very
different etiology, such as the poly-Q based pathologies.
We therefore set to study the effects of the Drosophila
Lipocalins GLaz and NLaz on a poly-Q triggered ataxia
model, the Type I Spinocerebellar Ataxia (SCA1) [30], to
focus on their effect on protein and organelle quality
control systems, the other major factor whose deterior-
ation is causative to aging. Until now, no Lipocalin has
been tested for its ability to modify poly-Q-based neuro-
degeneration and this work represents a first test for
extracellular lipid-binding proteins as modulators of pro-
teostasis under neurodegenerative conditions.
Results
The Lipocalin GLaz is up-regulated upon neurodegeneration
by pathogenic human Ataxin 1, and it is expressed locally in
the fly retina
The expression of human ApoD is boosted upon various
neurodegenerative conditions (for reviews see [25-27]),
but SCA1 is still unexplored. We therefore tested whether
the Drosophila Lipocalins change their expression in
SCA1-affected flies.
To assay expression of the Drosophila Lipocalins in a
poly-Q-based neurodegenerative disease, we have used
the GAL4/UAS system to express a pathogenic version
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(hATXN182Q) in Drosophila retinal photoreceptors using
the gmr:GAL4 driver. In this model of SCA1 [30] photo-
receptors accumulate nuclear inclusions of the human
protein and start degenerating during late pupal stage
when flies develop at 25°C. We first tested GLaz expres-
sion. Figure 1A shows that its expression increases 3-
fold in the photoreceptors degeneration model of SCA1
when assaying mRNA levels in 5–6 days old fly heads.gmr>+ gmr>hA
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Figure 1 GLaz expression and rescue with the GAL4/UAS system of th
of GLaz transcripts in 5–6 day old fly heads. Statistical differences assayed b
using the direct reporter transgene glaz:GLaz-GFP[FX]. Arrows point to GLa
basal glial cells. C-F, Adult (5-6d old) Drosophila eye morphology of control (gm
+GLaz2). Representative examples of light microscopy (C), surface filter-process
histochemistry of paraffin sections (E), and Ataxin 1 immunohistochemistry on p
in the histological sections (E), and arrows point to inclusion bodies of the polySince these results demonstrate that GLaz, like ApoD
in vertebrates, is part of the natural response of the tis-
sue to the neurodegenerative insult, we characterized its
expression in the Drosophila eye, searching for cells that
might influence the tissue response to the neurodegener-
ative condition. To assay for GLaz expression we used
two independent insertions of a fusion protein construct
(glaz:GLaz-GFP[FX] and glaz:GLaz-GFP[F2] [12]). These
reporters show GFP-positive cells in the retina (Figure 1B).TXN182Q
gmr>hATXN182Q
+GLaz2
22C10 GLaz
b
glaz:GLaz-GFP[FX] (3d)
e SCA1 neurodegeneration model in Drosophila. A, RT-qPCR levels
y Mann–Whitney U-test. *p < 0.05. B, Native over-expression of GLaz
z-positive retinal support cells, and arrowhead indicates GLaz-positive
r > +), degenerated (gmr > hATXN182Q) and rescue test (gmr > hATXN182Q
ed image of the central retinal region in C (D), hematoxilin/eosin
araffin sections (F) are shown. Double arrows mark the retina thickness
-Q protein (F).
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marker 22C10 (Figure 1Bb), suggesting that support ret-
inal cells (arrows in Figure 1B) and retinal basal glia
(arrowhead in Figure 1B) are the source of this Lipocalin.
Co-expression of GLaz with extended poly-Q human
Ataxin 1 ameliorates photoreceptor degeneration
To test whether GLaz is able to protect cells that are de-
generating due to the expression of hATXN182Q, we either
expressed the Lipocalin in the degenerating photorecep-
tors (using the same controller to drive the expression of
the poly-Q protein and GLaz), or in the cells naturally ex-
pressing the GLaz protein under the control of its native
promoter (using a glaz:GLaz-GFP construct).
We first demonstrated that the expression of the UAS:
GLaz transgene does not directly cause an alteration in
the amount of hATXN182Q produced in photoreceptors
by quantifying the hATXN182Q immunolabeling signal in
eye imaginal discs of 3rd instar larva (Additional file 1).
This time point was chosen to avoid variation in the num-
ber of of hATXN182Q-expressing cells, since cell death
caused by neurodegeneration is not present yet [30].
GLaz produces a significant rescue of photoreceptor
degeneration when co-expressed with hATXN182Q
(Figure 1C-F, Additional file 2). Two UAS:GLaz and
two EP insertions upstream of GLaz were used to drive
the expression of the Lipocalin under the control of
gmr:GAL4. The adult eye external morphology was
inspected (Figure 1C; Additional file 2A) and the de-
gree of surface regularity analyzed (Figure 1D) and
quantified (Figure 2B) by estimating a regularity index
according to the variance of intensity maxima (See
Methods section; [31]). Histochemistry of paraffin sections
(Figure 1E) shows severe atrophy of retinal cells in the
hATXN182Q-expressing flies, while the retinal epithelial
pattern is reasonably preserved in the presence of gain-of-
function constructs of GLaz. The degeneration observed
in hATXN182Q-expressing photoreceptors of 3 days old
flies is already extensive, and no further deleterious effect
is observed when native GLaz expression is eliminated in
the null mutant background (Additional file 3A). The ex-
pression of an unrelated control protein (LacZ) does not
rescue the degeneration phenotype of the SCA1 model
(Additional file 2C, Figure 2B). Specificity was further
tested by simultaneously over-expressing GLaz in photore-
ceptors (with the UAS:GLaz2) and decreasing the expres-
sion of GLaz with a UAS:GLazRNAi construct. The
rescue is abolished in this situation (Additional file 3B,
Figure 2B). Moreover, the rescue observed with GLaz
gain-of-function is dependent on temperature (due to the
temperature sensitivity of the GAL4/UAS system) and the
transgene expression levels. The GLaz-triggered rescue at
25°C shows a similar extent when comparing flies with ei-
ther one or two copies of the UAS:hATXN182Q transgenelocated in the 1st chromosome (Additional file 2D,
Figure 2B). However, a lesser rescue was obtained either
at 29°C or with a 3rd chromosome UAS:hATXN182Q in-
sertion line that shows a higher expression level (results
not shown).
Human Ataxin 1 was detected by immunohistochem-
istry in the retina sections (Figure 1F). Nuclear inclusion
bodies of the extended poly-Q protein are evident in the
photoreceptors expressing hATXN182Q as previously de-
scribed [30]. The expression of GLaz does not fully abol-
ish the formation of these protein aggregates (arrows in
Figure 1F) in spite of the preserved tissue integrity.
Taken together our data show that GLaz ameliorates
the hATXN182Q-provoked degeneration, but there seems
to be a limited range of the disease severity where GLaz
can exert a beneficial effect when expressed by the de-
generating photoreceptors.
GLaz rescues degeneration of photoreceptor neurons in a
stable manner when produced by its native cell
expression domain
Since the Lazarillo-related fly Lipocalins are secreted
proteins [9,32], we further tested if GLaz expressed with
its native spatiotemporal pattern would be able to pro-
tect photoreceptors when accessing the degenerating cell
from the extracellular space. We tested the effect of
GLaz gain-of-function by expressing, in wild type back-
ground, the GLaz-GFP fusion protein under the control
of the native GLaz promoter (glaz:GLaz-GFP [F2] or
glaz:GLaz-GFP[FX] insertion lines) on the pathogenic
human poly-Q Ataxin 1-generated photoreceptor degen-
eration (Figure 2A,B and Additional file 4). The rescue is
present from early stages of degeneration in the pupal
eyes, 5 days after pupa formation (APF), to aged adult
flies (30 days old) (Additional file 4). These results show
that the rescue does not require Lipocalin expression in
the degenerating cell, and that the GLaz protecting effect
can be exerted when the source of protein is a different
cell. The support and basal glial cells in the retina are the
closest natural source of GLaz in this case (Figure 1B).
Therefore GLaz can act as an extrinsic factor protecting
the photoreceptors in a non-cell-autonomous manner.
This paracrine neuroprotective mechanism is stable
enough to maintain retinal rescue in aged flies (30 days
old flies, Figure 2A and Additional file 4).
GLaz-GFP protein localization is evident in cells under-
going degeneration in 5–6 days old flies (Figure 2Ca,b).
When analyzing mildly degenerated regions of retinas
at 4d-APF, no GLaz-GFP signal is detected in the
hATXN182Q-expressing photoreceptors (Figure 2Cc).
However, more degenerated regions of retina showed
GLaz protein signal co-localizing with the photorecep-
tor marker 4C5 (Figure 2Cd). These results suggest a
potential incorporation of the extracellular protein into
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Figure 2 Rescue of hATXN182Q-dependent photoreceptor degeneration by GLaz over-expressed with a native spatiotemporal pattern.
A, Representative examples of scanning electron microscopy and magnified images of retinas degenerated (gmr > hATXN182Q), and co-expressing
different GLaz expression transgenes (glaz:GLaz-GFP[FX] and glaz:GLaz-GFP[F2]). B, Quantitative estimate of degeneration by computing a regularity
index based on the variance (σ) of the local intensity maxima distances. A percent recovery of the degeneration is indicated for each genotype. 20–35
eyes/genotype were used to compute regularity indexes. Average ± S.E.M. are represented. Asterisk represents statistically significant differences
(Student’s t-test, *P < 0.05) with respect to the degenerated gmr > hATXN182Q genotype. C, a,b: GLaz expression revealed by GFP fluorescence
immunohistochemistry of paraffin sections of retinas of flies expressing hATXN182Q and the transgene glaz:GLaz-GFP[FX]. Nuclei are shown with DAPI
staining. c,d: Double fluorescence immunohistochemistry revealing GLaz and the photoreceptor marker rhodopsin (4C5). DAPI stains nuclei in C.
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ternalization of exogenous ApoD observed in cultured
astrocytes [18].
The Lipocalin NLaz is up-regulated by pathogenic poly-Q
Ataxin 1 expressed in the fly retina, and rescues
photoreceptor neurodegeneration
The Drosophila Lipocalin NLaz is expressed by neurons
in the fly CNS and PNS [32]. The native expression of
NLaz increases 2-fold in retinal SCA1 model fly heads
(Figure 3A). However, when NLaz expression was
assayed by either a direct reporter construct (nlaz:GFP
[R2]) or by a nlaz:GAL4 construct driving the expression
of GFP (UAS:CD8-GFP), none of the NLaz reporters
showed expression in the fly retina (not shown).
Nevertheless, co-expressing NLaz with hATXN182Q in
retinal photoreceptors under the control of the gmr:
GAL4 driver protects cells from degeneration (Figure 3B
and Additional file 2B). The rescue level obtained with
NLaz was similar to that with GLaz, as quantified by the
degree of surface regularity (Figures 2B and 3D, 66-84%
rescue with GLaz, 80% rescue with NLaz). Interestingly,the rescue attained by each Lipocalin is comparable to
that obtained when both GLaz and NLaz are over-
expressed in photoreceptors (Figure 3C,D, 80% rescue),
suggesting that both proteins could be acting through
the same mechanism and no additive effect is obtained.
Since GLaz is natively expressed in cells within the niche
of the degenerating photoreceptors in the SCA1 model,
we focused on this Lipocalin for the subsequent search of
the cellular mechanism causative of neuroprotection.
Over-expressing GLaz decreases apoptotic cell death in
the presence of expanded human Ataxin 1
Terminal deoxynucleotidyl transferase dUTP nick-end la-
beling (TUNEL) analysis reveals that photoreceptor cells
die by apoptosis upon hATXN182Q expression (Figure 4A).
GLaz over-expression causes a reduction in the number of
apoptotic cells detected in the fly retina (Figure 4A). To
have a quantitative estimate of the cell death rescue, we
measured the levels of hATXN1 mRNA by qRT-PCR
under two assumptions: (i) at pupal stage, hATXN1
mRNA levels are similar when degeneration is not yet
present (hATXN1 protein levels show no difference,
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Figure 3 NLaz is over-expressed in response to hATXN182Q-dependent photoreceptor degeneration, and its over-expression with the
GAL4/UAS system rescues the pathogenic phenotype. A, RT-qPCR levels of NLaz mRNA in 5–6 day old fly heads. Statistical differences were
assayed by Mann–Whitney U-test. *P< 0.05. B, Representative fly eyes and hematoxilin/eosin histochemistry of paraffin sections showing the degenerated
phenotype (gmr > hATXN182Q) and the NLaz rescue (gmr > hATXN182Q + NLazC5). Arrows mark the retina thickness in the histological sections.
C, Photoreceptor degeneration rescue observed when co-expressing hATXN182Q with the Lipocalins NLaz and GLaz. D, Quantification of photoreceptor
degeneration rescue for NLaz and the co-expression of NLaz and GLaz. Asterisk represents statistically significant differences (Student’s t-test, *P < 0.05)
with respect to the degenerated gmr > hATXN182Q genotype.
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would contribute significantly to the pool of detectable
mRNA transcribed from the human transgene once the
degeneration has started. GLaz does increase the levels
of human Ataxin 1, both when co-expressed in photo-
receptor neurons and when expressed by the nearby
support cells and basal glial retinal cells (Figure 4B), in
agreement with the decrease observed in the number of
TUNEL-positive cells.
GLaz alters the expression of a SCA1 phenotype-modifier
controlling lipid peroxide clearance
Among the genes found to modify SCA1-induced neurode-
generation in Drosophila, two genes involved in lipid man-
agement were uncovered [30,33]: Glutathione S transferase
S1 (GstS1), a homologue of the mammalian hematopoietic
prostaglandin D synthase (HPGDS), and Vibrator (Vib)
a phosphatidylinositol transfer protein, homologue of
PITPN-alpha in vertebrates. Over-expression of GstS1
or Vib suppresses the neurodegeneration caused by the
poly-Q human Ataxin 1, and the loss of function of
GstS1 enhances the phenotype [30,33].Although GstS1 is classified as part of the constitu-
tively expressed oxidative stress defensive enzymes [34],
no transcriptional regulation upon neurodegeneration
has been described for GstS1 or Vib. We explored the
putative transcriptional regulation of these two genes in
our system. While no modification of Vib transcript
levels was seen in the SCA1 model either alone or com-
bined with over-expression of GLaz, a 4-fold induction
of the GstS1 transcript was obtained upon hATXN182Q-
induced photoreceptor degeneration (Figure 4C). This
induction was significantly reduced when GLaz is over-
expressed (Figure 4C).
The direct cause of GstS1 up-regulation under
SCA1-induced neurodegeneration remains to be ex-
plored. However, since GLaz controls lipid peroxide
levels [12], we propose a mechanistic link between the
lower levels of oxidized substrates upon GLaz gain-of-
function and the decreased GstS1 transcription. Thus,
the ectopic expression of poly-Q hAtaxin 1 results in
the induction of both GLaz and GstS1 genes, and they
contribute to an efficient lipid peroxide clearance.
Other lipid management genes, like Vib, are not
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Figure 4 Effects of GLaz over-expression on cell death due to hATXN182Q-dependent degeneration, and on SCA1-modifiers expression.
A, TUNEL analysis of apoptotic cell death in paraffin sections of degenerated (gmr > hATXN182Q) and GLaz rescued (gmr > hATXN182Q + GLaz2)
retinas. Representative examples of retina sections showing a decreased number of apoptotic nuclei (white arrows) in flies that over-express GLaz.
B, hATXN1 mRNA levels in fly heads of the SCA1 model and lines expressing a double dose of GLaz. C, RT-qPCR expression levels of the SCA1
neurodegeneration modifiers GstS1 and Vib. Statistical differences of RT-qPCR data were assayed by Mann–Whitney U-test. *P < 0.05.
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neurodegenerative phenotype.
SCA1-dependent build-up of ubiquitinated proteins is
reduced by GLaz over-expression
To address whether GLaz over-expression modifies any
of the protein quality control systems altered in the
SCA1fly model, we analyzed by immunohistochemistry
and immunoblot the expression pattern of ubiquitinated
proteins (Figure 5). Abundant ubiquitinated protein aggre-
gates are evident upon neurodegeneration (Figure 5Ab,d)
when compared to controls (driver alone, not shown, or
GLaz over-expression in wild type background,
Figure 5Aa). This accumulation is greatly reduced whenGLaz is co-expressed with hATXN182Q (Figure 5Ac,e,f). A
quantitative analysis by immunoblot demonstrates that
over-expressing GLaz, either in the degenerating photo-
receptor or in the native GLaz expression domain, results
in a significant decrease of ubiquitinated protein levels
(Figure 5B).
Over-expression of GLaz reduces SCA1-dependent
Atg8a induction
A defense mechanism against lipid peroxides in a ROS-
promoting environment, and a mechanism controlling
proteostasis seem unconnected processes at first glance.
However, links between these mechanisms are starting
to emerge. GstS1 is oxidized while catalyzing the
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Figure 5 Decrease of ubiquitinated proteins build-up attained by GLaz over-expression. A, Ubiquitin HRP-immunohistochemistry on
paraffin sections of control, degenerated and GLaz-rescued retinas shows the decrease in ubiquitin labeling when over-expressing GLaz. B, Ubiquitinated
protein load measured by ubiquitin immunoblot signal in different lines expressing the pathogenic hATXN182Q alone or in combination with
GLaz-expressing transgenes. Statistical differences were assayed by Student’s t-test. *P< 0.05.
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thione, and this fact has another consequence: the in-
duction of autophagy by the Jun-N-terminal Kinase
(JNK) when this kinase is released from the inhibitory
interaction of the reduced form of GstS1 protein [34].
On the other hand, ubiquitinated proteins are known to
be degraded by autophagy in neurons [35-37]. Thus, we
hypothesized that the protective effects of proteins like
Lipocalins, influencing both lipid oxidation and proteos-
tasis, might be related to the membrane-mediated
process of autophagy, potentially adding another link be-
tween these processes.
In order to understand the protective mechanism of
Lipocalins we studied the endogenous expression of the
Drosophila Atg8a gene, a homologue of LC3 in verte-
brates [38], as a first approximation to the levels of au-
tophagy activity. Transcription of Atg8a is known to bestrongly up-regulated upon starvation [39] and to show
a strong correlation with autophagy activity. Although au-
tophagy initiation might not be dependent on Atg8a up-
regulation, this transcriptional response contributes to re-
plenish the protein consumed by autophagic activity [5].
By measuring the transcription levels of the Atg8a gene
we can therefore assess whether autophagic activity is in-
creased in the SCA1 model of photoreceptor degener-
ation. A twofold Atg8a induction is observed (Figure 6A).
This indication of increased autophagic activity is in agree-
ment with the observed induction of GstS1 (Figure 4C),
which upon oxidation would contribute to JNK-based au-
tophagy induction, and supports the view that inducing
autophagy might be a general response in poly-Q based
pathologies of different etiologies [3]. Neurodegeneration-
triggered Atg8a induction in the fly head is similar in
extent to the induction obtained upon starvation in this
CA
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expression of hATXN182Q and starvation increase autophagic activity, monitored by Atg8a mRNA levels. B, Atg8a expression is decreased by
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the changes observed in larval and fat body tissues [39].
If flies expressing hATXN182Q are starved, Atg8a tran-
scription is further increased, suggesting that different
mechanisms of autophagy induction are acting in an
additive manner.
When GLaz is over-expressed in the photoreceptors
or in retinal support cells and basal glial cells, the
SCA1-dependent Atg8a induction is significantly re-
duced (Figure 6B). Thus, a paradox arises from the
data presented so far (Figures 5 and 6), since GLaz
gain-of-function reduces accumulation of ubiquiti-
nated proteins, but at the same time reduces the levels
of an indicator of autophagic activity induction (Atg8a)
and an oxidative stress defensive enzyme that affects
autophagic activity (GstS1). When autophagy is further
stimulated by feeding SCA1 model flies with rapamy-
cin (a TOR signalling inhibitor; see [40] for a review),
two important consequences are observed: 1) more au-
tophagic induction results in higher levels of ubiquitinated
proteins, instead of enhanced clearance, and 2) GLazover-expression reduces the accumulation of ubiquiti-
nated proteins (Figure 6C). The first observation sug-
gests that autophagy promotion alone is not beneficial
in the SCA1 neurodegeneration model, leading instead
to autophagic stress [6,7] that ultimately makes ubiqui-
tinated proteins clearance less efficient. Although rapa-
mycin treatment, in addition to autophagy induction,
might have wider effects on protein homeostasis, it is
clear that the combination of rapamycin treatment with
GLaz over-expression results in an enhanced clearance
of ubiquitinated proteins (Figure 6C).
These data could support different scenarios: (i) The
GLaz antioxidant properties contribute to maintain in-
duction of autophagy and other antioxidant systems at
an appropriate level where these mechanisms are most
effective. (ii) GLaz is not directly acting on the induction
or initiation steps of autophagy, but rather promoting its
resolution, making the process to progress more effi-
ciently. (iii) The GLaz contribution to the protein quality
control systems is independent of autophagy (e.g., by po-
tentiating proteasomal function).
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and rapamycin-stimulated autophagy
To discern between the alternatives stated above we
monitored the accumulation of p62, a protein acting as a
decision point for the degradation of aggregasomes (ag-
gregates of misfolded proteins too large to be degraded
by the proteasome system). p62 docks aggregasomes to
newly formed autophagic membranes, thus controlling
their entrance in the autophagosome [41-43]. If autoph-
agy is working properly, p62 should also be degraded in
the process. Therefore, measurement of endogenous p62
can be used to quantitatively assess the flow of autoph-
agy of protein aggregates [44,45] serving as a readout of
autophagic degradation efficiency [5]. The hypothesis
that GLaz might be promoting the resolution of autoph-
agy predicts a reduction in p62 accumulation. Levels of
p62 show a 30-40% decrease upon GLaz over-expression
(Figure 7A). Moreover, p62 protein levels increase upon
rapamycin-induced autophagy in both, wild type control
flies (Figure 7B) and in flies undergoing photoreceptor neu-
rodegeneration (Figure 7C), as expected by the known tran-
scriptional up-regulation of p62 in autophagy-inducing
conditions [39]. Over-expression of GLaz reduces p62
levels in the SCA1 model with or without further induction
of autophagy by rapamycin (Figure 7A,C). The effect of
GLaz over-expression on autophagy markers does not sup-
port its role in clearance of aggregate-prone proteins by an
autophagy-independent proteasome mechanism.B
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changes are accompanied by transcriptional changes
upon GLaz over-expression. We then measured the p62
transcript levels by qRT-PCR (Figure 7D) and found no
significant changes upon hATXN182Q or GLaz over-
expression alone, while a 25% decrease is observed by
over-expressing GLaz in the SCA1 model compared to
the neurodegenerative condition. These results show
that GLaz over-expression results in both p62 mRNA
and protein levels decrease in the SCA1 model.
In the absence of neurodegeneration, a loss of GLaz
function increases Atg8a mRNA and p62 protein levels
In basal conditions, when no neurodegeneration-triggered
autophagy activity is present, GLaz null mutant flies show
higher levels of p62 protein (Figure 8A), while over-
expressing GLaz under basal conditions does not
change p62 protein levels (Figure 8B). Transcript levels
of p62 slightly decrease in GLaz null mutants, but do
not change significantly by GLaz gain-of-function in
the absence of neurodegeneration (Figure 8C). Atg8a
transcript levels increase in GLaz null mutant flies, but
no changes in Atg8a mRNA levels are observed in flies
over-expressing GLaz (Figure 8D). These results sug-
gest, on the one hand, the existence of a GLaz-
dependent effect on basal autophagy progression, since
the absence of GLaz expression results in increased
Atg8a expression and accumulation of p62 without atin
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hand, increasing GLaz expression levels does not
affect, by itself, the expression of genes monitoring au-
tophagic activity or the accumulation of p62 protein in
the absence of a deteriorating cellular context.Knocking-down key autophagy genes rescues
SCA1-triggered neurodegeneration, and further
GLaz-dependent rescue is abolished
We used four genetic manipulations to decrease autoph-
agy activity in our SCA1 Drosophila model: Atg1K38Q, a
del Caño-Espinel et al. Molecular Neurodegeneration  (2015) 10:11 Page 12 of 18kinase-negative form of Atg1 that inhibits starvation-
and rapamycin-induced autophagy [46] by impairing the
induction of autophagosome formation; Atg4aC98A, a
dominant-negative form of Atg4a suppressing autophagy
by defective processing of Atg8a/LC3 [47]; RNAi silen-
cing of Atg8a (JF02895 line) [Dr. Juhász personal com-
munication] and of p62 (KK105338 line) [47], that
reduce Atg8a or p62 up-regulation respectively and im-
pair the replenishment of both proteins when they are
consumed by autophagic activity. The four constructs
were expressed with the UAS/GAL4 system in the neu-
rodegenerating photoreceptors with or without over-
expression of GLaz (Figure 9).
All forms of autophagy reduction tested produce a sig-
nificant rescue of photoreceptor degeneration (Figure 9),
suggesting that in this neurodegenerative condition, au-
tophagy must be contributing to neuronal death. These
data, together with the observed accumulation of ubiqui-
tinated proteins upon autophagy induction in the SCA1
model flies, suggest that hATXN182Q expressing cells are
suffering autophagic stress [6,7]. GLaz over-expression
under all four conditions of autophagy down-regulation
results in a rescue of the rough eye phenotype, that is ei-
ther similar or even slightly better than when autophagy
is not genetically modified. No significant additive effect
of both rescuing manipulations is observed, thus reflect-
ing epistatic relationship between GLaz and autophagy
control genes.
Discussion
We have used the Drosophila retina as a cellular sub-
strate to model the poly-Q-based SCA1 neurodegenera-
tive disease, and found that two lipid-binding proteins,
the Drosophila Lipocalins GLaz and NLaz, are able to
counteract cellular damage and maintain cell viability
and tissue integrity to a reasonable extent. Both Lipoca-
lin genes are part of the endogenous transcriptional re-
sponse to the neurodegenerative insult triggered by the
expanded poly-Q human Ataxin 1. The beneficial effects
of GLaz occur when the Lipocalin is either expressed by
the degenerating neuron, or in a paracrine manner by
the nearby support cells or basal glial cells. Neurode-
generation rescue is abolished by a GLaz interfering
RNA construct, further supporting the effect specificity.
Moreover, the neuroprotective effect of GLaz is persist-
ent as the animal ages.
The fact that nuclear inclusions of poly-Q-Ataxin 1
are still present in GLaz over-expressing flies, suggests a
role for GLaz in processes occurring in the cytoplasm of
the affected cells. We have detected co-localization of
the GLaz-GFP fusion protein with photoreceptor
markers in the neurodegenerative SCA1 model. Like-
wise, human ApoD is internalized by murine astrocytes,
and the internalized exogenous Lipocalin is observed inintracellular membranous and vesicular compartments,
but not inside the nucleus [18]. A similar intracellular
traffic of GLaz is expected, and therefore worth to study.
Interestingly, we have also recently found that ApoD, in
addition to perform extracellular functions in injured
peripheral nerves (controlling lipid mediators), promotes
myelin degradation by macrophages [22], an intracellular
process that also involves the formation of phagosomes.
Induction of autophagy has been shown in a Huntington
disease model in response to the pathogenic mutant
version of huntingtin [3], and induction of mRNA and
protein p62 expression have been demonstrated upon
expression of poly-Q expanded huntingtin [48]. On the
other hand, experimental induction of autophagy is
beneficial in most, but not all, proteinopathies tested so
far [4]. Until now, the role of autophagy in SCA1 patho-
genesis was unclear. Here we show that autophagy is
also part of the tissue response to the expression of the
human pathogenic version of Ataxin 1. We demonstrate
that inhibition of the autophagy process in vivo rescues
the fly retina from SCA1-triggered damage and that in-
duction of autophagy in SCA1 flies compromises ubi-
quitinated proteins clearance. These results agree with
the conclusions reached by recent works showing that
activation of autophagy in neurons under autophagic
stress compromises neuronal survival [49]. Similarly,
autophagy induction, autophagosome accumulation and
increased levels of ubiquitinated proteins are accom-
panied by decreased mTOR signaling [50]. Therefore,
our data support that cells might be undergoing autoph-
agic stress in this model [6,7], and that this cellular re-
sponse is probably lowering the threshold for the onset
of apoptotic cell death [7]. This information is relevant
in the context of the use of this Drosophila retinal de-
generation model of SCA1 to search for genetic modi-
fiers [30,33].
Our data support the view that GLaz beneficial effect
on SCA1 neurodegeneration concurs with the modula-
tion of neurodegeneration-triggered selective autophagy.
GLaz shows epistatic relationships with autophagy genes
involved in the induction of phagofore formation; Atg8a/
LC3 processing (conditioning the expansion into autop-
hagosomes); targeting aggregated proteins cargo into the
phagofore; and replenishing Atg8 and p62 levels upon
autophagic activity. Moreover, in the SCA1 model, over-
expressing GLaz lowers endogenous Atg8a and p62
transcript levels, as well as p62 protein levels, suggesting
a decrease in autophagic activity that might counteract
excessive autophagy induction. The loss of GLaz func-
tion increases Atg8a mRNA levels and leads to p62 pro-
tein accumulation in basal conditions, also suggesting a
role in the modulation of basal autophagic activity. Al-
though the observed decrease in p62 protein upon GLaz
over-expression in SCA1 model flies, or the p62 protein
BD
A
C
E
gmr>hATXN182Q
+Atg1K38Q
gmr>hATXN182Q
+Atg1K38Q+GLaz2
gmr>hATXN182Q
+Atg4C98A
gmr>hATXN182Q
+Atg4C98A+GLaz2
gmr>hATXN182Q
+Atg8-RNAi
gmr>hATXN182Q
+Atg8-RNAi+GLaz2
gmr>hATXN182Q
+p62-RNAi
gmr>hATXN182Q
+p62-RNAi+GLaz2
0
5
10
15
20
R
eg
ul
ar
ity
 in
de
x 
(σ
)
gmr>hATXN182Q
gmr>+
gmr>hATXN182Q+GLaz2
gmr>hATXN182Q+Atg1K38Q+GLaz2
gmr>hATXN182Q+Atg1K38Q
gmr>hATXN182Q+Atg4C98A+GLaz2
gmr>hATXN182Q+Atg4C98A
gmr>hATXN182Q+Atg8a-RNAi+GLaz2
gmr>hATXN182Q+Atg8a-RNAi
gmr>hATXN182Q+p62-RNAi+GLaz2
gmr>hATXN182Q+p62-RNAi
100%
0%
67%
38%
63%
74%
48%50%
42%
52% 52%
*
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could also be interpreted as signs of autophagy flux alter-
ations [5], the small but parallel changes in p62 transcrip-
tion under neurodegenerative conditions cast doubts on
this scenario as the sole explanation.
We have previously shown that GLaz and NLaz have
beneficial effects under oxidative stress elicited either ex-
perimentally, through normal aging [12-16], or evokedby Friedreich Ataxia, a mitochondrial dysfunction-based
neurodegenerative disease [29]. The control of lipid per-
oxidation levels lies at the base of these outcomes. Here
we find that the Lipocalin GLaz is also able to rescue
photoreceptors from pathogenic SCA1-induced apop-
totic cell death by an apparently different mechanism.
Interestingly, several control points of autophagy are ei-
ther directly regulated by the cell redox state or are part
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lipid peroxide levels are involved: (i) The activity of the
cysteine protease Atg4a is redox sensitive [51,52]. (ii)
The expression of p62 is induced by oxidative stress [53]
and, in turn, p62 works as a signaling molecule promot-
ing antioxidant response through its effect on Nrf2 tran-
scription factor activation [54]. (iii) GstS1 activity
modulates autophagy though its regulation of the JNK
pathway [34]. Interestingly, GLaz null mutants display
increased oxidative stress sensitivity, higher levels of
lipid peroxidation and apoptotic cell death [12]; pheno-
types that are often associated with autophagy malfunc-
tion. Thus, a parsimonious hypothesis would be that the
Lipocalin-mediated control of lipid peroxide levels influ-
ences autophagy at several steps, slowing down the
process and ultimately making it more efficient. These
functions will promote clearance of aggregated proteins
and would prevent crossing the threshold to apoptotic
cell death programs. We thus propose that GLaz partici-
pates in the optimization of autophagy, contributing to
make this process efficient and preventing autophagic
stress, which would, in due time, develop alongside the se-
vere degeneration produced by a relentless hATXN182Q
expression under the UAS-GAL4 system.
It is known that autophagy defects lead to neurode-
generation even in cases where poly-Q protein expan-
sions are not involved; e.g., in the Pink1 and Parkin loss-
of-function leading to Parkinson disease, where mito-
phagy defects are proposed to induce neuronal death
[55,56]. Therefore, the Lazarillo-related Lipocalins, with
their potential to modulate autophagy, might be useful
in many other neurodegenerative diseases. Also, it is
known that autophagy efficacy decreases with aging [57].
How is autophagy activity modulation contributing to
the well-known longevity modulation phenotypes of
GLaz and other Lazarillo-related Lipocalins [12-16] be-
comes an interesting future research avenue. Another
member of the Lipocalin family, Lcn2, has been involved
in autophagy modulation in murine embryonic cells,
where loss of Lcn2 function results in a decrease in LC3
protein expression [58].
In summary, the Lazarillo-related Lipocalins, known
to protect membranes from lipid peroxidation and its
collateral damages, are also contributing to prevent au-
tophagic stress under poly-Q-based neurodegenerative
conditions. Understanding this pleiotropic nature of
ApoD and Lazarillo-related Lipocalins will help us to
better explain why ApoD is a key element in the nervous
system response to such a wide array of neurodegenera-
tive and injury-triggered diseases.
Conclusions
From our analysis of Lazarillo-related Lipocalins in the
Drosophila retina model of SCA1 we can conclude that:1. Two extracellular lipid binding proteins, GLaz and
NLaz, are able to counteract cellular damage and
maintain tissue integrity when the retina is suffering
from the deleterious effects of expressing a poly-Q-
expanded version of human Ataxin 1.
2. Both Lipocalins are part of the endogenous
transcriptional response to the neurodegenerative
insult, as ApoD is in many other nervous system
diseases. GstS1, which contributes to lipid-peroxide
clearance, is also induced in the SCA1 model.
3. The beneficial effects of GLaz can be exerted both,
from within the degenerating neuron, or in a
paracrine manner from the nearby support and basal
glial cells.
4. The neuroprotective effect of GLaz is persistent
with age.
5. GLaz gain-of-function reduces the amount of
ubiquitinated proteins in neurodegenerative
conditions.
6. GLaz loss-of-function increases Atg8a mRNA, and
leads to p62 protein accumulation without a
concomitant increase in its mRNA levels.
7. GLaz gain-of-function decreases SCA1-dependent
induction of Atg8a and p62 mRNA and decreases
p62 protein levels in the degenerated tissue.
8. Genetic down-regulation of autophagy rescues
SCA1-triggered neurodegeneration, and
pharmacological up-regulation of autophagy does
not promote ubiquitinated proteins clearance in
the SCA1 model, suggesting that cells are
undergoing autophagic stress.
9. Epistasis genetic analysis with down-regulators of the
autophagy process demonstrates that GLaz beneficial
effects concur with a restrain in the extent of selective
autophagy activity, which ultimately leads to an
improved clearance of aggregation-prone proteins.
10. GLaz is able to improve ubiquitinated protein
clearance even when combining SCA1-dependent
with pharmacological inductions of autophagy. This
result opens the possibility of an effective combination
of therapeutic interventions, not only for SCA1, but
for many other neurodegenerative diseases.
11. Lazarillo-related Lipocalins, including ApoD, can now
be understood as useful and efficient players in the
endogenous protection against the two major factors
contributing to aging and neurodegeneration: ROS-
dependent damage and proteostasis deterioration.
Methods
Fly strains and husbandry
Flies were grown under standard laboratory conditions
as described [12]. Fly females were used in all experi-
ments. Unless stated otherwise, experiments were per-
formed at 25°C.
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control (WTG10) in Canton S background were previously
described [12]. We used a construct (glaz:GLaz-GFP) con-
taining 1.9 kb of the native 5’ genomic region upstream
and the full-length GLaz gene, in frame with the coding
sequence of GFP, thus producing a GLaz-GFP fusion pro-
tein expressed under the control of the native GLaz regu-
latory sequences [12]. Two independent transformant
lines with insertions of this construct were used: 1) glaz:
GLaz-GFP[FX] and 2) glaz:GLaz-GFP[F2], located in the
first and second chromosome respectively.
NLaz expression was characterized by various reporter
constructs, with 3 kb of the native 5’ genomic region up-
stream of NLaz followed by GFP (nlaz:GFP[R2]). Alter-
natively, we used the same NLaz 5’ genomic region to
drive the expression of GAL4 to express a membrane
bound GFP (UAS:CD8-GFP line).
We used the line gmr:GAL4 to drive transgenes ex-
pression to the eye photoreceptors. The UAS:GLaz and
UAS:NLaz lines have been reported [13,16]. The UAS:
hATXN182Q; gmr:GAL4 line was kindly provided by Dr.
J. Botas. UAS:Atg1K38Q [46], UAS:Atg4aC98A [47], UAS:
Atg8a RNAiJF02895, and UAS:p62 RNAiKK105366 [47,59]
were kindly provided by Dr. Gábor Juhász. All other fly
lines were obtained from the Bloomington stock Center.
To combine the neurodegeneration model with GLaz
over-expression and with different forms of autophagy in-
hibition (or other control transgenes) we constructed a fly
line UAS:hATXN182Q; gmr:GAL4 UAS:GLaz2/CyO (with
two transgenes in the second chromosome). After the
scheme of crosses, presence of GLaz cDNA transgene was
confirmed by PCR amplification from genomic DNA.
Immunohistochemistry
Fly heads were fixed with 4% paraformaldehyde and em-
bedded in paraffin following standard procedures. Tissue
sections (4 μm) were performed with a rotary microtome
(Microm), serially mounted on Polysine™ slides (Menzel-
Gläser), and dried. The sections were dewaxed in xylene
and rehydrated through an ethanol series into phosphate
buffered saline (PBS). Larval optic imaginal discs were
dissected and fixed in 4% paraformaldehyde. The tissue
was then blocked and permeabilized with TritonX-100
(0.1% in PBS) and 2% normal goat serum.
The following primary antibodies were used: Rabbit
serum anti-p62 (a kind gift of Dr. Juhasz, Loránd Uni-
versity, Hungary; [47]); Rabbit serum anti-Atxn1 (a kind
gift of Dr. J. Botas, Baylor College of Medicine, USA);
Mouse monoclonal P4D1 anti-Ubiquitin (Cell Signaling);
Rabbit serum anti-GFP (Santa Cruz Biotechnology, Inc.);
Mouse monoclonal 4C5 anti-Rhodopsin (DSHB); Mouse
monoclonal 22C10 anti-MAP1B (DSHB).
For HRP-IHC, the secondary antibodies HRP-conjugated
Goat anti-Rabbit IgG (Abcam) and HRP-conjugated Goatanti-Mouse IgG (Dako) were used. HRP development was
achieved with DAB (0.03%) and H2O2 (0.002% in 50 mM
Tris, pH 8.0). Hematoxilin/Eosin and HRP-IHC sections
were mounted after dehydration and clearing in Eukitt™.
For fluorescence IHC, the following secondary anti-
bodies were used: FITC-conjugated Goat anti-Mouse and
Cy3.5-conjugated Goat anti-Rabbit (Abcam). After washes
in PBS, the sections were mounted with Vectashield-DAPI
(Vector Labs).
The TUNEL FITC labeling kit (Roche) was used to
assay apoptotic cell death in fly head tissue sections ac-
cording to the manufacturer’s protocol.
Labeled sections were visualized and photographed
with an Eclipse 90i (Nikon) fluorescence microscope
equipped with DS-Ri1 (Nikon) digital camera. Images
were acquired and processed with the NIS-Elements BR
3.0 software (Nikon).
Eye external morphology
Flies were anesthetized with CO2 and immobilized with
adhesive tape. Fly eyes were photographed with a Nikon
DS-L1 digital camera, in a Nikon SMZ1000 stereomicro-
scope equipped with a Plan Apo 1× WD70 objective.
Images were processed with Adobe Photoshop 6.0 using
a surface filter. Local intensity maxima were obtained
with ImageJ software, and nearest neighbor distances
were calculated for each ommatidia. A regularity index
was estimated as the variance of distances, and a percent
recovery was calculated considering 0% the average
degenerated eye and 100% the control wild type eye.
Samples of 20–35 flies (3d old) per condition and geno-
type were used to calculate the average ± S.E.M. regular-
ity index. We have developed an optimized version of
this methodology, with a freely available ImageJ plugin
for automated analysis of fly eye pictures [31].
For scanning electron microscopy images, the flies were
immobilized and pictures were taken with an ESEM-FEI-
Quanta 200FEG scanning electron microscope.
Quantitative RT-PCR
Drosophila heads (30–50 per condition and genotype)
used for mRNA expression studies were stored at −80°C,
and RNA was extracted using QIAzol™ Lysis Reagent
(Qiagen). RNA concentration was measured with a
Nanodrop spectrophotometer and its integrity assayed by
gel electrophoresis. Following DNAse treatment, 500 ng
of total RNA was reverse-transcribed with PrimeScript™
(Takara Bio Inc., Otsu, Japan) according to the manufac-
turer’s instructions using Oligo-dT primers and random
hexamers. The resulting cDNA was used as template for
RT-qPCR using SybrGreen (SYBR® Premix Ex Taq™ kit,
Takara) in quintuplicate PCR reactions in a Rotor-Gene
RG-3000 thermal cycler (Corbett Research). Cycling con-
ditions were 30 sec 95°, (5 sec 95°, 15 sec 55°, 15 sec 72°) ×
Table 1 RT-qPCR primer sequences
Gene Primer orientation Primer sequence
NLaz Forward 5′-CGAGTACGCAGCCTATCCAT-3′
Reverse 5′-CCAGGTAGTTGGCCTTCGT-3′
GLaz Forward 5′-GCGAACAATCGAAGTTTTCC-3′
Reverse 5′-ACAAGATGGCGAAGTTCTCG-3′
hATXN1 Forward 5′-GTGGCCGTGATACAGTTCG-3′
Reverse 5′-AGCCGTTCTTCAGGTTCTTG-3′
GstS1 Forward 5′-AAGGACAACGATGGTCACCTGGC-3′
Reverse 5′-CGGTGAACTTAGACCTCGGTGACG-3′
Vib Forward 5′-GGCCAATCGCACTCCCCAGTTC-3′
Reverse 5′-TAACACCTCGATGCCCTCGCC-3′
Atg8a Forward 5′-CATCGGTGATTTGGACAAGA-3′
Reverse 5′-AGTCCTCCTCGTGATGTTCC-3′
p62 Forward 5′-CGTAAGGACCTTCTGGATCG-3′
Reverse 5′-CGTCGTGGATGGTGAAATTG-3′
L18 Forward 5′-AGAACCGAGCCCAAATCC-3′
Reverse 5′-CGACCACGATGGTAGACTCC-3′
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check for the absence of unspecific amplifications. The
primers used for RT-qPCR are shown in Table 1. The gene
Rpl18 was used as the reference gene.
Transcription levels of mRNA were calculated with
the ΔΔCT method [60]. Statistically significant differ-
ences of gene transcriptional changes were evaluated
with a Mann–Whitney U-test [61], using ΔCT of each
replica (calculated by subtracting the average CT of the
reference gene). The statistical level of significance was
set at P < 0.05.
Immunoblot analysis
Proteins from fly heads (30–50 per condition and geno-
type) were solubilized by homogenization in lysis buffer,
and total protein concentration was evaluated by BCA
analysis (Pierce).
Immunoblot analyses were performed with 10–20 μg
of total protein/lane transferred to PVDF membranes
using standard procedures and exposed to the following
antibodies: Rabbit serum anti-p62 (Dr. Juhasz, Loránd
University, Hungary; [47]); Mouse monoclonal P4D1
anti-Ubiquitin (Cell Signaling). HRP-conjugated Goat
anti-Rabbit or mouse IgG (DAKO) were used as second-
ary antibodies. HRP-conjugated anti-β actin antibody
(Sigma, St Louis, MO, USA) was used to normalize
protein loads. Membranes were developed with ECL
(Millipore, Billerica, MA, USA), and the signal visual-
ized with a digital camera (VersaDoc, BioRad). The in-
tegrated optical density of the immunoreactive protein
bands was measured in images taken within the linear
range of the camera to avoid signal saturation.Statistical analysis
Statistical tests were performed with SigmaPlot (v 11.0)
software. A P-value < 0.05 was defined as a threshold for
significant changes. Means and dispersion values were
calculated from experimental triplicates. The particular
tests used are stated in figure legends.
Additional files
Additional file 1: GLaz expression does not alter early levels of
human Ataxin 1 expressed in photoreceptors by the GAL4/UAS
system. A-C, Third instar eye imaginal discs labeled with anti-hATXN1
polyclonal antibody 11NQ. hATXN1 is not detected in driver-only controls.
Photoreceptors are immunopositive when hATXN182Q is expressed by
the gmr driver. A similar fluorescence level is observed when both
hATXN182Q and GLaz2 transgenes are co-expressed. D, Relative amounts
of immunofluorescence signal quantified in a 400 μm2 area/disc.
Statistical differences assayed by Student’s t-test. *P < 0.05.
Additional file 2: Effect of different forms of GLaz and NLaz
gain-of-function in hATXN182Q-driven photoreceptor degeneration.
Representative examples of Drosophila adult eyes of different genotypes.
Light microscopy (upper panels) and surface image (lower panels) are
shown in all cases. A, SCA1-affected retinas and lack of rescue upon
LacZ over-expression. B, NLaz gain-of-function rescue with two different
trangene lines. C, GLaz gain-of-function rescue with a GLaz trangene and
two EP insertion lines. D, GLaz gain-of-function rescue when two copies
of SCA1 transgene are present.
Additional file 3: GLaz loss-of-function does not rescue the
hATXN182Q photoreceptor degeneration and GLaz RNAi counteracts
rescue of GLaz over-expression. Representative examples of Drosophila
adult eyes. A, Light microscopy (upper panels) and surface image (lower
panels) are shown in GLaz loss-of-function control retinas (gmr driver)
and upon expression of pathogenic hATXN182Q in GLaz null-mutant
background. B, GLaz gain-of-function rescue of neurodegeneration is
reverted when GLaz RNAi is co-expressed in the fly retina.
Additional file 4: Expressing GLaz with its native spatiotemporal
pattern rescues hATXN182Q-dependent photoreceptor degeneration
throughout aging. A-D, Examples of Drosophila eyes of degenerated
(gmr > hATXN182Q) and two different GLaz expression transgenes
(glaz:GLaz-GFP[FX] and glaz:GLaz-GFP[F2]) of pupa (5 dAPF) (A), 1 day (B),
3 days (C) and 30 days (D) old flies.
Abbreviations
APF: Days after pupa formation; ApoD: Apolipoprotein D; Atg8a/
LC3: Autophagy-specific gene 8a/ Microtubule-associated protein 1A/1B-light
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activating sequences; Vib: Vibrator.
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